GlobeNewswire

Appian and VASS Extend Strategic Alliance across the UK and Latin America

Del

Partnership expansion makes VASS' Appian implementation expertise available in new markets

RESTON, Va. and LONDON, March 26, 2018 (GLOBE NEWSWIRE) -- Appian (NASDAQ:APPN) and VASS today announced an extension of the two companies' strategic alliance. VASS consultants are now available to implement low-code business process management (BPM) solutions on the Appian platform across the UK and Latin America. VASS has accumulated extensive Appian implementation expertise as an Appian partner in Spain for the past 10 years.

Founded in 1999, VASS is an IT consulting firm with 1,200 employees, and presence in multiple countries in Europe and America. Appian and VASS formed a strategic alliance in 2008 in VASS' home country of Spain. A decade of effective collaboration establishes a solid foundation for expanding the partnership to the UK and to Latin America.

This announcement is backed by executive commitments to grow in new markets and acquire new customers through these additional initiatives:

  • Increase in the number of Appian trained and certified specialists at VASS by 67% by the end of 2018
  • Jointly go-to-market to meet increased demand to create enterprise applications, faster, to meet business needs
  • Grow the business in Latin America by helping organisations achieve Digital Transformation through the Appian platform and services delivered by VASS

"We have a long history with VASS, and a successful track-record of servicing clients together," said Marc Wilson, Senior Vice President of Industry Markets at Appian. "Taking our partnership to new markets will benefit many more organisations that are struggling to achieve digital transformation."

About Appian

Appian provides a leading low-code software development platform that enables organizations to rapidly develop powerful and unique applications. The applications created on Appian's platform help companies drive digital transformation and competitive differentiation. For more information, visit www.appian.com.

About VASS

VASS is an IT consulting company with 100% private capital with offices in Spain, England, the United States, Mexico, Colombia, Peru, Chile and Brazil with capacity to provide services globally. With a staff of more than 1,300 people, it bases its strategy on technological innovation and collaboration with the main market leaders to help transform the business of its customers. Thanks to this business model, VASS is a company that grows at double digits per year. As a sign of its commitment to society, the company allocates 2% of the profit and its workers 1% of their time to solidarity actions.

This press release includes forward-looking statements. All statements contained in this press release other than statements of historical facts, including, without limitation, the results obtained by customers using the Appian low-code software development platform, increase in demand for enterprise applications, growth of Appian's business internationally, and increase in the number of Appian-trained resources are forward-looking statements. The words "anticipate," believe," "continue," "estimate," "expect," "intend," "may," "will" and similar expressions are intended to identify forward-looking statements. Appian has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that Appian believes may affect its financial condition, results of operations, business strategy, short-term and long-term business operations and objectives and financial needs. Those forward-looking statements are subject to a number of risks and uncertainties, including, without limitation, risks that Appian's recent growth may not be indicative of future growth, risks related to market adoption of our low-code platform, risks associated with international operations, and risks associated with our strategic relationships with third parties, and the risks and uncertainties set forth in the "Risk Factors" section of Appian's Quarterly Report on Form 10-K for the year ended December 31, 2017 filed with the Securities and Exchange Commission, and subsequent reports that Appian has filed with the Securities and Exchange Commission. Moreover, Appian operates in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for Appian's management to predict all risks, nor can Appian assess the impact of all factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements Appian may make. In light of these risks, uncertainties and assumptions, Appian cannot guarantee future results, levels of activity, performance, achievements or events and circumstances reflected in the forward-looking statements will occur. Appian is under no duty to update any of these forward-looking statements after the date of this press release to conform these statements to actual results or revised expectations, except as required by law.

For more information:

Nicole Greggs

Director of Media Relations, Appian

+1 703.260.7868

Nicole.Greggs@appian.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Appian Corporation via Globenewswire

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Allied Esports™ Announces Formation of World’s First Affiliate Program for Esports Venues17.12.2018 15:30Pressemelding

Allied Esports™ Property Network to Offer Members Access to Global Events and Content, Expertise in Design and Operations, and Unique Sponsorship OpportunitiesFortress Esports Joins Program with Partnership Covering Exclusive Rights to New Properties in Australia and New Zealand ORANGE COUNTY, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Allied Esports™, a global esports entertainment company, today announced the formation of the world’s first esports venue affiliate program – the Allied Esports Property Network – created for global partners interested in participating in Allied Esports’ global event programming, and licensing Allied Esports’ design, development and operations expertise for their own dedicated esports venues. The Allied Esports Property Network will provide members with access to Allied Esports’ global platform of events and content production, providing participants and viewers with integrated experiences both in-person and online. Affiliate members will be fully incorpo

Aryaka Names Cloud and Software Industry Veteran, Deepak Kumar, as Senior Vice President of Customer Success17.12.2018 15:00Pressemelding

SAN MATEO, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Aryaka®, the leading SD-WAN as a Service provider, announced today that Deepak Kumar, a 20-year cloud and enterprise software industry veteran, has joined the company’s leadership team as Senior Vice President, Customer Success. "We’re thrilled to welcome Deepak to Aryaka; his leadership will help us further enhance our end-user customer experience worldwide,” said Matt Carter, CEO of Aryaka. “His expertise in building and nurturing enterprise relationships will be critical as we continue to grow in 2019 and beyond.” Before joining Aryaka, Kumar was the SVP & GM at [24]7.ai, a Sequoia portfolio company in the customer experience domain. As SVP Business Development, he was responsible for building out strategic partnerships and alliances. His hard work grew the channel driven revenue significantly. As General Manager, Kumar was responsible for the Customer Acquisition Cloud product line. The product line was built based on strategic a

Biome Grow receives new consumer sales amendment from Health Canada for its Nova Scotia brand, Highland Grow17.12.2018 14:00Pressemelding

Sales amendment granted for Highland Grow—Amendment to License Significantly Increases Product Availability for Medical and Adult Consumer-Use Markets TORONTO, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Biome Grow Inc. (“Biome” or the “Company”) (CSE: BIO) (Frankfurt: 6OTA) (OTC: ORTFF) is pleased to announce its Nova Scotia-based subsidiary, Highland Grow Inc. (“Highland Grow”), has received its sales authorization via an amendment to its existing license from Health Canada under the Cannabis Act. This authorization will allow Highland Grow to sell cannabis products to end consumers through appropriate medical and recreational cannabis channels, dramatically increasing product availability. The sales authorization will position Biome Grow to serve the rapidly growing domestic and international cannabis markets. "Biome Grow has been steadfast in its focus on a regional business strategy and building provincial brands that can serve the unique requirements of its local cannabis consumers. This n

Alkermes and Biogen Announce Submission of a New Drug Application to U.S. Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis17.12.2018 13:30Pressemelding

DUBLIN, Ireland and CAMBRIDGE, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Alkermes plc (Nasdaq: ALKS) and Biogen Inc. (Nasdaq: BIIB) today announced that Alkermes has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for diroximel fumarate (BIIB098), a novel oral fumarate in development for the treatment of relapsing forms of multiple sclerosis (MS). Alkermes is seeking approval of diroximel fumarate under the 505(b)(2) regulatory pathway, and the NDA submission includes data from EVOLVE-1, a Phase 3 pivotal trial that evaluated long-term safety in relapsing-remitting MS (RRMS) with approximately 700 patients dosed with diroximel fumarate. If approved, Biogen intends to market diroximel fumarate under the brand name VUMERITY™. This name has been conditionally accepted by the FDA and will be confirmed upon approval. “Diroximel fumarate was designed to provide patients with relapsing forms of multiple sclerosis a novel oral fumarate with a differentiated

SoftServe Documentary Receives “The Best Corporate Media of Ukraine 2018” Award17.12.2018 13:00Pressemelding

25th anniversary documentary takes prize in “The Best Corporate Movie” category AUSTIN, Texas, Dec. 17, 2018 (GLOBE NEWSWIRE) -- SoftServe, a leading digital authority and consulting company, announces the Ukrainian Association of Corporate Media, a public organization uniting professionals in the field of marketing, PR, journalism, and advertising, recognized SoftServe in its annual competition – “The Best Corporate Media of Ukraine 2018.” SoftServe’s 25th anniversary documentary took second place in the “The Best Corporate Movie Category.” The documentary honors the company’s 25th anniversary with an inside look at how SoftServe evolved over the past quarter century to become a leading digital authority. In the documentary, SoftServe’s founders and leadership share their inspiring stories and highlight the company’s achievements over the years. “It is a great honor to receive this recognition from the Ukrainian Association of Corporate Media for our 25th anniversary documentary,” sai

Bombardier to supply a further 20 FLEXITY trams to Karlsruhe17.12.2018 10:00Pressemelding

Albtal-Verkehrs-Gesellschaft expands its fleet to 62 trams The dual-system vehicles operate on both the tram network and regional railway network BERLIN, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Global mobility solution provider Bombardier Transportation received a call-off order from Albtal-Verkehrs-Gesellschaft mbH (AVG), the transport company of the Alb valley region in southwest Germany, for the delivery of 20 further dual-system BOMBARDIER FLEXITY trams. This third order is based on a framework agreement for a total of 75 vehicles from 2009. The order is valued at approximately 87 million euro ($98 million US). The vehicles will be delivered between May 2020 and March 2021. "Striving to provide attractive local transport services, we have decided to order 20 additional dual-system vehicles from Bombardier Transportation. This will allow us to purposefully enlarge our vehicle fleet offering high-quality standards to our passengers," said Dr. Alexander Pischon, CEO of Albtal-Verkehrs-Gesel